Caribou Biosciences (CRBU) Preferred Shares Issued (2021)
Caribou Biosciences (CRBU) reported Preferred Shares Issued of -$408000.0 for Q2 2021, down 100.37% on a QoQ basis from $109.2 million in Q1 2021.
Caribou Biosciences (CRBU) has 1 years of Preferred Shares Issued data on file, last reported at -$408000.0 in Q2 2021.
- Quarterly Preferred Shares Issued changed N/A year-over-year to -$408000.0 in Q2 2021, while the trailing twelve-month figure through Mar 2022 was -$408000.0 (changed N/A YoY) and the FY2021 annual result came in at $108.8 million, changed N/A from the prior year.
- Preferred Shares Issued declined to -$408000.0 in Q2 2021 per CRBU's latest filing, from $109.2 million in the prior quarter.
- Across five years, Preferred Shares Issued topped out at $109.2 million in Q1 2021 and bottomed at -$408000.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -408,000.00 |
| Jun 30, 2021 | -408,000.00 |
| Mar 31, 2021 | 109.24 Mn |
| Mar 31, 2021 | 109.24 Mn |